Erik Kuld CEO

Inventive Emerges from Stealth with $6.5M Funding to Revolutionize Enterprise SaaS with AI Integration

Today marks a significant milestone for Inventive as they announce their official launch alongside the successful closure of a $6.5 million seed funding round led by Wing VC. Additional contributions came from Tokyo Black and a distinguished group of angel investors, including former executives from Google and Meta. This funding is earmarked to propel Inventive’s…

Read More

InVirtuoLabs Nets €2.85M to Revolutionize Drug Discovery with AI Precision

A beacon of innovation has emerged from the serene shores of Lugano, as InVirtuoLabs secures €2.85 million in its inaugural funding round. This Swiss biotech pioneer, dedicated to reshaping the future of pharmaceuticals, is set to harness artificial intelligence to slash the staggering costs and timelines that have long burdened drug development. With this capital,…

Read More

Armata Pharmaceuticals Secures $5.25 Million DoD Grant to Advance Groundbreaking Phage Therapy for Staphylococcus aureus Bacteremia

Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a leader in the development of cutting-edge bacteriophage therapies, has been awarded an additional $5.25 million in non-dilutive funding by the U.S. Department of Defense (DoD). This significant grant, facilitated through the Medical Technology Enterprise Consortium (MTEC) and managed by the Naval Medical Research Command (NMRC) and the Joint…

Read More

Augustine Therapeutics Secures EUR 17 Million in Series A Funding to Propel Groundbreaking Neurological Disease Treatment

Augustine Therapeutics, a pioneering biotechnology firm specializing in innovative therapies for neurodegenerative and cardiometabolic diseases, announced a significant milestone today with the successful completion of a EUR 17 million (USD 18.5 million) first closing of its Series A funding round. This financing, led by Asabys Partners and supported by Eli Lilly and Company and the…

Read More

Nomic Bio Secures $42 Million in Oversubscribed Series B Funding to Enhance Protein Profiling Capabilities

Nomic Bio, a leader in protein profiling, has successfully completed a $42 million Series B funding round that was oversubscribed. This significant capital infusion will propel the company’s efforts to enhance its cutting-edge protein profiling platform and expand its commercial operations, catering to the rising demand in the proteomics field. Led by a prominent U.S.-based…

Read More

From Graphite to Silicon: How Coreshell’s $1 M Win at Startup World Cup 2025 May Shift the EV Battery Landscape

The global spotlight turned to San Francisco on October 17, 2025, as ten startup finalists—filtered from thousands across dozens of countries—pitched before a sharp-eyed panel of Silicon Valley investors. At the heart of the debate: who would claim the coveted $1 million investment prize at the grand finale of the Startup World Cup 2025, organised…

Read More

LillianCare Raises €1.5 Million to Expand Innovative Healthcare Access Across Germany

LillianCare, a trailblazing healthcare innovator based in Berlin, has successfully closed a €1.5 million extension funding round aimed at revolutionizing primary care delivery in Germany’s underserved regions. The investment underscores robust investor confidence in LillianCare’s mission to combat the nation’s critical shortage of physicians through its pioneering hybrid care model. Renewed Support from Key Investors…

Read More

Ewake Unveils Revolutionary AI-Powered Software Reliability Agents, Raises €2M to Transform the Industry

The race to keep software systems reliable and efficient is becoming more critical than ever as businesses face mounting pressure to deploy faster while maintaining uptime. Paris-based Ewake has emerged from stealth mode with a bold proposition—AI-driven agents that promise to transform the way engineering teams handle software reliability. The company raised €2 million in…

Read More